Curium Announces Ioflupane I 123 Injection Availability for
Exciting news from Curium! Starting April 5, 2024, our Ioflupane I 123 Injection will be delivered Monday through Friday....
Source: globenewswire.com
Accurium News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Accurium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Accurium Today - Breaking & Trending Today
Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer
PARIS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the first patients in Greece have been injected with PYLCLARI® (INN: Piflufolastat (18F) also known as (18 F)-DCFPyL, indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical se
Source: yahoo.com
Accurium expands its education offering to accountants
SMSF education specialist Accurium is expanding its services to provide a comprehensive professional development offering for accountants. Doug McBirnie, managing director of Accurium, said more
Source: smsfadviser.com
EU Approves Piflufolastat (18F) PSMA PET Imaging Agent for Prostate Cancer
The European Commission has approved piflufolastat (18F) for the detection of prostate-specific membrane antigen–positive lesions with positron emission tomography in adults with prostate cancer.
Source: onclive.com
Curium Receives Positive CHMP Opinion of PYLCLARI® for
If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic...
Source: globenewswire.com